Senators push for quicker generic drug access

(AP)—Two senators want to do away with the agreements that pharmaceutical companies make with one another to keep lower-priced generic copies of brand-name drugs off the market.

Democratic Sen. Amy Klobuchar of Minnesota and Republican Charles Grassley of Iowa say such "pay-for-delay" deals force consumers to pay higher prices for critical drugs. Their bill would make such agreements illegal unless the companies can prove in court that they aren't anti-competitive.

Grassley says Congress, in his words, "should be doing all we can to see that the American consumer has access to lower-priced drugs as soon as possible."

Representatives of the tell a Senate antitrust subcommittee chaired by Klobuchar that the agreements sometimes shorten the time for to reach the market, particularly in patent disputes.

© 2013 The Associated Press. All rights reserved.

Citation: Senators push for quicker generic drug access (2013, July 23) retrieved 29 March 2024 from https://medicalxpress.com/news/2013-07-senators-quicker-drug-access.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

US: 'Pay to delay' generic drugs can be illegal (Update)

 shares

Feedback to editors